|
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying ...
Vertex Pharmaceuticals Incorporated announced today that the European Committee for Medicinal Products for Human Use has issued a positive opinion by consensus recommending the approval of KALYDECO™ for people with cystic fibrosis ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene.
finance.yahoo.com
Global Herbal Supplements and Remedies Industry
NEW YORK, May 21, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Herbal Supplements and Remedies Industry http://www.reportlinker.com/p080429/Global-Herbal-Supplements-and-Remedies-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Vitamin_aThis ...
finance.yahoo.com
New Phase 3 data for Tradjenta® (linagliptin) tablets in black or African American patients with type 2 diabetes ...
RIDGEFIELD, Conn. and INDIANAPOLIS, May 24, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced Phase 3 study results for linagliptin 5 ...
finance.yahoo.com
New York College of Health Professions Announces The Don King Scholarship Fund
NEW YORK, May 23, 2012 /PRNewswire/ -- There was a magical moment at the 2012 Commencement Ceremony for the graduating class of New York College of Health Professions. Before an audience of about 1,000, ...
finance.yahoo.com
Monument honors historic doctor
SHAMONG — The legacy of the “Black Doctor of the Pines” lives on.
www.phillyburbs.com
Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO ™ (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator ...
www.pharmiweb.com
First oral agent may 'rapidly restore lost vision'
Washington, May 7 (ANI): There may be new found hope for patients whose eyesight is threatened when medicine injected directly into the eyes is unsuccessful in causing abnormal blood vessels to recede.
in.news.yahoo.com
Shamong students and historical society join forces to erect monument at Still Family Cemetery
SHAMONG — The legacy of the “Black Doctor of the Pines” lives on.
www.phillyburbs.com
Eu Yan Sang to tap in halal market
SINGAPORE:Eu Yan Sang International Ltd (EYSI) is set to open more stores and tap the potential of the halal market in Malaysia. EYSI is a global healthcare and wellness company with a strong foundation in traditional Chinese medicine.
www.btimes.com.my
Eu Yan Sang Set To Expand And Tap Halal Market In Malaysia
SINGAPORE, May 17 (Bernama) -- Eu Yan Sang International Ltd (EYSI) is set to open more stores and tap the potential of the halal market in Malaysia. EYSI is a global healthcare and wellness company with a strong foundation in traditional Chinese medicine.
www.bernama.com
|
